Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank92
3Y CAGR+13.1%
5Y CAGR+25.8%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+13.1%/yr
vs +76.8%/yr prior
5Y CAGR
+25.8%/yr
Recent deceleration
Acceleration
-63.6pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$6.57M+16.9%
2024$5.63M+6.5%
2023$5.28M+16.3%
2022$4.54M+3.0%
2021$4.41M+111.5%
2020$2.08M-10.4%
2019$2.33M+400.0%
2018$465000.00+1.8%
2017$457000.00+3.2%
2016$443000.00-